Title |
State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization. Volume 2, Biopharmaceutical characterization: The NISTmAb case study / John E. Schiel, editor, National Institute of Standards and Technology, Gaithersburg, Maryland, Darryl L. Davis, editor, Janssen Research and Development, LLC, Spring House, Pennsylvania, Oleg V. Borisov, editor, Novavax, Inc., Gaithersburg, Maryland |
|